GS protein mutations and pituitary tumors: functional correlates and possible therapeutic implications (Q41081527)

26 September 2017

1 reference

title

GS protein mutations and pituitary tumors: functional correlates and possible therapeutic implications (English)

1 reference

26 September 2017

Faglia G

1

1 reference

PubMed ID

8769403

26 September 2017

Arosio M

series ordinal

2

1 reference

PubMed ID

8769403

26 September 2017

Spada A

series ordinal

3

1 reference

26 September 2017

1 August 1996

1 reference

26 September 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

26 September 2017

45

1 reference

26 September 2017

117-119

1 reference

26 September 2017

8 Suppl 1

1 reference

Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

Two G protein oncogenes in human endocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

Molecular genetic studies of sporadic pituitary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

Gs alpha and Gi2 alpha mutations in clinically non-functioning pituitary tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

G protein gene mutations in patients with multiple endocrinopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

G Protein Mutations in Tumors of the Pituitary, Parathyroid and Endocrine Pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

Characteristics of acromegalic patients with a good response to octreotide, a somatostatin analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990103-1

10.1016/S0026-0495(96)90103-1

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

8769403